{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 6,
        "Importance": 5,
        "Impact": 6,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 5,
        "Specificity": 6,
        "Sector_Spread": 8,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "ITB iShares Dow Jones U.S. Home Construction Shares $ITB $SH $MRK $MO #ITB #stocks #pennystocks",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 4,
            "Impact": 5,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 4,
            "Specificity": 7,
            "Sector_Spread": 9,
            "Tech_Mentions": 1
        },
        {
            "News_content": "WGO Winnebago Industries Inc. Company Info $WGO $MVIS $MRK $DB #WGO #nasdaq #pennystocks",
            "Correlation": 7,
            "Sentiment": 4,
            "Importance": 3,
            "Impact": 4,
            "Duration": 2,
            "Virality": 2,
            "Source_Score": 4,
            "Specificity": 6,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$GILD $MRK: Pharmaceutical Stocks Including Gilead (NASDAQ:GILD) making ...",
            "Correlation": 6,
            "Sentiment": 7,
            "Importance": 6,
            "Impact": 7,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 6,
            "Specificity": 5,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "MRK Merck & Co., Inc. Change $MRK $QLD $SSYS $JD #MRK #stocks #investing",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 5,
            "Impact": 6,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 5,
            "Specificity": 6,
            "Sector_Spread": 8,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Merck's EMEND successful in late stage CINV study in moderately-emetogenic chemo $MRK $CR",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 8,
            "Impact": 8,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 7,
            "Specificity": 9,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        }
    ]
}